STAT | Reporting from the frontiers of health and medicine
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
Latest health, science and medicine news from STAT
To keep up with the latest developments in biotech, pharma and the life sciences, bookmark this page.
Reporting from the frontiers of health and medicine - STAT
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
Regulating generative AI: FDA's limitations laid bare by experts
1 天前 · Generative AI poses unique challenges to the FDA's regulatory process: from initial evaluation and review, to post market monitoring.
STAT Health - Science, medicine and healthcare news
Health, science, and medicine news for patients and practitioners: Latest developments on long Covid, breast cancer, opioids, abortion pills and more.
About Us - STAT health, life science, medicine and biotech news
STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Millions of new readers turned to us as we sounded the alarm early on about the Covid-19 pandemic.
Latest Covid surge: New variants, hard-to-find tests, fewer 'novids'
2024年7月18日 · The virus, like other pathogens that most people shake off, can still occasionally cause severe cases. It is also still killing a few hundred people each week, the vast majority of whom are older ...
Most popular stories today: life sciences, medicine, health - STAT
Here are today's most popular biotech, pharma and medical stories at STAT. Sign up for a free newsletter or our premium subscription, STAT+
STAT's Who to Know: 12 changemakers in Chinese biopharma
2024年10月7日 · STAT profile series on key players in life sciences looks at the 12 top players in Chinese biotechnology, from researchers to pharma corporate executives.
STAT Business: News on hospitals, health care, pharma and more
Exploring the intersection of finance, pharma, and biotech and the impact on health care, the hospital industry and medical research.